Currently Viewing:
The American Journal of Managed Care April 2016
Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization Risk
S. Scott Sutton, PharmD; James W. Hardin, PhD; Thomas J. Bramley, RPh, PhD; Anna O. D’Souza, BPharm, PhD; and Charles L. Bennett, MD, PhD, MPP
Medicaid Managed Care Reduces Readmissions for Youths With Type 1 Diabetes
Kathleen Healy-Collier, CSSBB, DHA; Walter J. Jones, PhD; James E. Shmerling, DHA, FACHE; Kenneth R. Robertson, MD, MBA; and Robert J. Ferry, Jr, MD, FAAP
Assessing the Impact of an Integrated Care System on the Healthcare Expenditures of Children With Special Healthcare Needs
Mircea I. Marcu, PhD; Caprice A. Knapp, PhD; David Brown, PhD; Vanessa L. Madden, BSc; and Hua Wang, MS
The Role of Health IT and Delivery System Reform in Facilitating Advanced Care Delivery
Jennifer King, PhD; Vaishali Patel, PhD; Eric Jamoom, PhD; and Catherine DesRoches, DrPH
Lost in Translation: Healthcare Utilization by Low-Income Workers Receiving Employer-Sponsored Health Insurance
Bruce W. Sherman, MD; Wendy D. Lynch, PhD; and Carol Addy, MD, MMSc
Currently Reading
Patient Safety Intervention to Reduce Unnecessary Red Blood Cell Utilization
Scott Hasler, MD; Amanda Kleeman MS; Richard Abrams, MD; Jisu Kim, MD; Manya Gupta, MD; Mary Katherine Krause, MS; and Tricia J. Johnson, PhD
Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs Hyperglycemia
Courtney Hugie, PharmD, BCPS; Nancee V. Waterbury, PharmD, BCACP; Bruce Alexander, PharmD; Robert F. Shaw, PharmD, MPH, BCPS, BCNSP; and Jason A. Egge, PharmD, MS, BCPS
Costs for a Health Coaching Intervention for Chronic Care Management
Todd H. Wagner, PhD; Rachel Willard-Grace, MPH; Ellen Chen, MD; Thomas Bodenheimer, MD, MPH; and David H. Thom, MD, PhD, MPH
Four Steps for Improving the Consumer Healthcare Experience Across the Continuum of Care
Keith Roberts, MBA
Patient Perceptions of Clinician Self-Management Support for Chronic Conditions
Peter Cunningham, PhD

Patient Safety Intervention to Reduce Unnecessary Red Blood Cell Utilization

Scott Hasler, MD; Amanda Kleeman MS; Richard Abrams, MD; Jisu Kim, MD; Manya Gupta, MD; Mary Katherine Krause, MS; and Tricia J. Johnson, PhD
This study evaluated the impact of a patient safety intervention and national guideline to reduce unnecessary red blood cell transfusions in a large, urban academic medical center.
ABSTRACT

Objectives:
To measure the impact of a local patient safety intervention and a national guideline to reduce unnecessary red blood cell (RBC) transfusions in the Department of Medicine of an academic medical center.

Study Design: This was a retrospective, pre-post study. 

Methods: In May 2013, a clinical practice guideline, modeled after the 2012 AABB recommendations for RBC use, was implemented with the goal of decreasing unnecessary RBC transfusions. This was done using a previously developed model for change management in the Department of Medicine that included academic safety conferences, e-mail safety alerts, and feedback to providers on global blood product utilization. Data regarding the utilization of RBC products were obtained for the time before the AABB guideline, after the AABB guideline but before the local intervention, and after the local intervention (January 2011 through March 2014).

Results: Blood product use started to decline after the AABB guideline, but dropped much further after the focused, local interventions were implemented. The proportion of patients receiving a transfusion decreased from 12.6% prior to the AABB guideline to 8.8% after the intervention (P <.001). The percent of total blood use with a hemoglobin level above 8 g/dL decreased from 20.2% to 12.4%; the total units of RBCs transfused per 100 discharges also decreased from 33.4 to 21.7. The direct RBC costs per discharge dropped from $61.60 to $39.70.

Conclusions: Passive adoption of restrictive transfusion guidelines was shown to reduce blood product use on general medicine floors of an academic medical center, but the effect was greatly improved after a local, targeted intervention to improve patient safety was implemented.

Am J Manag Care. 2016;22(4):295-300
Take-Away Points
 
Although passive adoption of the AABB guideline that recommended a restrictive transfusion strategy for red blood cell (RBC) utilization moderately reduced blood product use, blood product use decreased significantly following a targeted patient safety intervention. 
  • The introduction of national guidelines targeted at reducing unnecessary utilization is often not sufficient to change physician behavior.
  • The effectiveness of national guidelines to reduce unnecessary RBC utilization could be improved through targeted patient safety initiatives.
  • A patient safety intervention that included a patient safety education conference and electronic alerts to supplement the education reduced unnecessary blood product use.
Red blood cell (RBC) transfusions are performed at a rate of approximately 13 million RBC units per year in the United States.1,2 Transfusions are commonly performed on surgical and trauma patients with blood loss, as well as patients with cancer who have decreased blood cell production.3 RBC transfusion practices vary widely, with significant differences existing among the hemoglobin threshold used to determine when transfusions are performed. As a result, the use of blood can deviate up to 4-fold among physicians performing the same procedure.4

Transfusion strategies are generally categorized as liberal or restrictive, with a liberal strategy using a higher hemoglobin threshold and a restrictive strategy using a lower hemoglobin threshold before transfusing.5 There is mounting evidence that liberal transfusion strategies have led to worse health outcomes. A systematic review of 494 studies concluded that 59% of transfusions were inappropriate in all scenarios where a patient’s hemoglobin level was 10 g/dL or above, and in 71% of scenarios where the patient’s hemoglobin level was 8 to 9.9 g/dL.6 These results are supported in studies that have evaluated transfusion strategies in specific populations, including head injury, hip surgery, and upper gastrointestinal (GI) bleeding.7-10 In response to these data, the AABB (formerly the American Association of Blood Banks) constructed a clinical guideline in 2012 recommending a restrictive transfusion strategy for RBC utilization when hemoglobin levels fall below 8 g/dL for hospitalized, stable adults.5

In addition to the patient safety advantages of adhering to a restrictive transfusion strategy, there are important implications for hospital costs and clinical resource management. The cost of blood ranges between $522 and $1183 per unit when including storage, labor, and waste.11 If a restrictive transfusion strategy was widely implemented, transfusions would be expected to decrease by an average of 40%.5 Thus, widespread adherence to a restrictive transfusion guideline would be expected to result in a significant impact on hospital finances through both the direct cost savings and the indirect benefits of improved patient safety outcomes.

Although clinical guidelines are an important component of moving toward value-based care,12 they have had a limited effect on changing physician behavior to date. Barriers to changing physician behavior include a lack of awareness about a guideline, lack of understanding about how a guideline applies to a physician’s practice, lack of consensus about the importance or relevance of a guideline, and its conflict with a physician’s current routine or training. Furthermore, adherence can be affected by “outcome expectancy,” or the belief that following the guideline will not significantly impact patient outcomes, and is thus not worth implementing into practice. Finally, many physicians may lack the resources needed to follow guidelines.13,14 Educational interventions to increase the adoption of guidelines, such as large conferences, small-group interactive sessions, and academic “detailing” have also been met with mixed results.14-16

Although the effectiveness of education interventions is unclear, organizations that successfully adopt evidence-based practices often have a culture that supports continuous quality improvement. The purpose of this study was to evaluate the impact of the AABB guideline and a subsequent education intervention that was grounded in continuous quality improvement methodology on RBC use at an urban academic medical center.

METHODS
Intervention and Study Design

In May 2013, the Department of Medicine at a large, urban academic medical center implemented an education intervention to integrate the AABB guidelines into practice. The intervention began with a patient safety conference for all residents and hospitalists. The conference consisted of a literature review presented by educators and an analysis of local practice patterns, and ended with recommendations. Following the conference, safety e-mail alerts were sent from June to October 2013, to all physicians, reminding them to comply with AABB guidelines when ordering transfusions.

This was a retrospective pre-post study of all patients who received care from the general medicine units of the academic medical center from January 1, 2011, to March 31, 2014. To be included in the study sample, patients were required to have an attending physician within the center’s Department of Medicine. Exclusions included patients who received a transfusion outside of a general medicine floor and patients with a principal diagnosis of neoplasm. During these 39 months, 23,368 patients were discharged from general medicine floors. Of these discharges, 1894 were diagnosed with neoplasms, 1151 had transfusions outside of a general medicine floor, 491 had incomplete patient demographic information, and 265 had a provider releasing the transfusion outside of the Department of Medicine; this left a final sample of 19,567 patients.

Clinical data were retrieved from the organization’s electronic health record, and cost data were obtained from the organization’s cost accounting system. Institutional review board approval was obtained prior to data collection. Data were separated into 3 time periods: “Pre-AABB Guideline” was defined as discharges occurring between January 1, 2011, and February 28, 2012; “Pre-Intervention” included discharges occurring between March 1, 2012, and May 31, 2013; and “Post-Intervention” consisted of discharges between June 1, 2013, and March 31, 2014.

The presence of an RBC transfusion, number of RBC transfusions performed with a hemoglobin level above 8 g/dL, average pre-transfusion hemoglobin concentration, units of RBCs transfused, RBC units transfused above 8 g/dL, and direct cost of RBCs were measured in all 3 groups. Total units of blood transfused and units transfused with hemoglobin >8 g/dL were expressed as units per 100 patient discharges. The direct cost of RBCs was reported in 2013 dollars and derived by multiplying the units per patient discharge by $183, the average direct cost of an RBC unit at our institution in March 2014.

Additionally, sociodemographic characteristics, hospital length of stay (LOS), and diagnosis category were collected. Diagnosis category was assigned using the Clinical Classification System for International Classification of Diseases, 9th Revision, Clinical Modification.17

Statistical Analysis

The first part of the analysis included all patients discharged from general medicine floors. A χ2 test was used to test the association between time period and whether a patient received a transfusion. This association was also tested through a binary logistic regression model controlling for patient age, sex, race/ethnicity, diagnosis category, primary payer, and LOS.

The second part of the analysis was limited to patients who received transfusions. First, a χ2 test was used to test the association between time period and whether a patient received a transfusion with hemoglobin >8 g/dL. A 1-way analysis of variance (ANOVA) was then used to test the association between time period and pre-transfusion hemoglobin concentration. Only the hemoglobin level prior to the patient’s first transfusion was included. A 1-way ANOVA was used to test the association between time period and the total units of RBCs transfused per 100 patient discharges, the total units of RBCs transfused above 8 g/dL per 100 patient discharges, and the total direct cost of RBCs for the hospital stay. Data were analyzed via Microsoft Office Excel 2010 and SPSS Statistical Package Software, version 15.0 (IBM Analytics, Armonk, New York).

RESULTS
Of the 19,567 patients in the sample, 11.1% received at least 1 transfusion. Of these patients, 909 (41.7%) were transfused between January 2011 and February 2012 (Pre-AABB Guideline period), 816 (37.5%) were transfused between March 2012 and May 2013 (Pre-Intervention period), and 453 (20.8%) were transfused from June 2013 to March 2013 (Post-Intervention period).

Analysis Part 1: All Patients Discharged From General Medicine Floors

Overall, the proportion of patients receiving a transfusion decreased over time, falling from 12.6% of patients in the Pre-AABB Guideline period to 8.8% of patients in the Post-Intervention period (P <.001) (Table 1). Patients in the Pre-AABB Guideline and Pre-Intervention periods were 1.62 and 1.34 times more likely, respectively, to receive a transfusion compared with patients in the Post-Intervention period (P <.001) (Table 2).

 Analysis Part 2: All Patients Receiving Transfusions on General Medicine Floors

Table 3 describes the subset of patients who received at least 1 transfusion during the study period (n = 2178; 11.1%). The results of the 1-way ANOVA test indicated a decline in the total number of RBC units transfused per 100 patient discharges, which dropped from 33.4 ± 5.8 units per 100 patient discharges in the Pre-AABB Guideline period to 21.7 ± 6.7 units per 100 patient discharges in the Post-Intervention period (P <.001).

There was a decrease in the proportion of patients receiving a transfusion with hemoglobin >8 g/dL, which fell from 20.2% of patients Pre-AABB Guideline to 14.8% of patients Pre-Intervention to 12.4% Post-Intervention (P <.001). This decline translated to an overall decrease in average pre-transfusion hemoglobin concentrations across all 3 time periods, decreasing from 7.4 ± 1.0 Pre-AABB Guideline to 7.0 ± 1.4 Post-Intervention (P <.001). A decline in the units of blood transfused with hemoglobin >8 g/dL also dropped from 5.9 ± 3.1 to 2.4 ± 1.6 units per 100 patient discharges throughout the study period (P =.004) (Table 3).

A decline in RBC associated cost was also observed. The average RBC unit cost per discharge fell from $61.60 ± $10.60 Pre-AABB Guideline to $52.60 ± $7.70 Pre-Intervention, and finally to $39.70 ± $12.3 Post-Intervention (P <.001 (Table 3). Calculating the RBC unit cost difference per patient discharge between the Pre-AABB Guideline and Post-Intervention periods ($21.90) and multiplying by total discharges (19,567), we were able to estimate annual savings of $131,851.48 in RBC acquisition costs.

DISCUSSION
The study aim was to determine whether an educational intervention to promote the AABB guideline was successful in decreasing unnecessary transfusions. The results suggest that the initial drop in transfusions between the Pre-AABB Guideline and Pre-Intervention periods may have been due to passive adoption of the AABB guidelines. However, the larger drop between the Pre- and Post-Intervention periods highlighted the effectiveness of an active intervention in further reducing the number of transfusions and suggests this targeted approach may hasten the adoption of clinical practice guidelines.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!